Previous 10 | Next 10 |
As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...
Support for biologics manufacturability and Industry 4.0 initiatives Agilent Technologies Inc. (NYSE: A) announced that it has joined the National Institute for Innovation in Manufacturing to Advance Biomanufacturing (NIIMBL). Membership in NIIMBL demonstrates Agilent...
Agilent looks fundamentally undervalued after losing 30% since its ATH. The company delivers consistently solid financial results and is forecasted to further increase its profitability. AI and machine learning will play a determinant role in the key markets of the company. Th...
Driven by the makers of life sciences tools, the healthcare stocks in the S&P 500 have pared the gains made last week as the sector is set to become the second worst performer in the broader index on Tuesday. IDEXX Laboratories (IDXX), Agilent Technologies (A), Bio-Rad Laboratories (BIO) ...
Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting , being held April 8 - 13, 2022 in New Orleans, Louisiana. “Cancer researc...
Agilent Technologies Inc. (NYSE: A) today announced CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx immunohistochemical assay to extend the use of the test to patients diagnosed with muscle-invasive urothelial carcinoma (MIUC) who have tumor cell PD-L1 expression...
Agilent Technologies Inc. (NYSE: A) today announced it has expanded CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx as an aid in identifying esophageal squamous cell carcinoma patients for treatment with Bristol Myers Squibb’s PD-1-targeted immunotherapeut...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Support for bioprocess, cell and gene therapy, and Industry 4.0 initiatives Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC). Joining AMBIC demonstrates the company’...
Many investors have likely heard the saying that "data is the new oil", which, I would note, was coined before the Putin invaded Ukraine and oil jumped back over $100/bbl. However, I would argue that potable water is more vital and essential than either oil or data. After all, without...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast,...